RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+6.62%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$6.76B
AUM Growth
+$6.76B
(-4.8%)
Cap. Flow
-$348M
Cap. Flow
% of AUM
-5.15%
Top 10 Holdings %
Top 10 Hldgs %
43.88%
Holding
93
New
7
Increased
14
Reduced
55
Closed
7
Top Buys
| 1 |
VERV
Verve Therapeutics
VERV
|
$117M |
| 2 |
The Beauty Health Co
SKIN
|
$73.4M |
| 3 |
ZY
Zymergen Inc. Common Stock
ZY
|
$60.9M |
| 4 |
ONEM
1Life Healthcare, Inc. Common Stock
ONEM
|
$36.5M |
| 5 |
Lifestance Health
LFST
|
$35M |
Top Sells
| 1 |
Medtronic
MDT
|
$116M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
$95.5M |
| 3 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$85.8M |
| 4 |
Beam Therapeutics
BEAM
|
$61.8M |
| 5 |
Biogen
BIIB
|
$45.6M |
Sector Composition
| 1 | Healthcare | 95.41% |
| 2 | Consumer Staples | 1.58% |
| 3 | Financials | 0.69% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Nurix Therapeutics
NRIX
$723M
| $84.6M | 1.25% |
3,190,077
-124,040
| -4% | -$3.29M |
|
27
Regenxbio
RGNX
$498M
| $83.1M | 1.23% |
2,138,201
-202,112
| -9% | -$7.85M |
|
28
Stoke Therapeutics
STOK
$1.08B
| $82.8M | 1.22% |
2,458,558
-85,504
| -3% | -$2.88M |
|
29
Repare Therapeutics
RPTX
$73.9M
| $81.8M | 1.21% |
2,624,396
-41,100
| -2% | -$1.28M |
|
30
Annexon
ANNX
$225M
| $77.1M | 1.14% |
3,425,038
-33,792
| -1% | -$761K |
|
|
EPZM
31
DELISTED
Epizyme, Inc
EPZM
| $70.8M | 1.05% |
8,515,060
-309,306
| -4% | -$2.57M |
|
32
Akero Therapeutics
AKRO
$3.65B
| $69.6M | 1.03% |
2,804,944
+291,198
| +12% | +$7.22M |
|
33
Scholar Rock
SRRK
$3.3B
| $66.7M | 0.99% |
2,307,028
+130,400
| +6% | +$3.77M |
|
34
Prothena Corp
PRTA
$452M
| $62.5M | 0.92% |
1,215,657
-641,415
| -35% | -$33M |
|
|
ZY
35
DELISTED
Zymergen Inc. Common Stock
ZY
| $60.9M | 0.9% |
+1,522,900
| New | +$60.9M |
|
|
IMGN
36
DELISTED
Immunogen Inc
IMGN
| $58.5M | 0.87% |
8,880,945
-807,121
| -8% | -$5.32M |
|
|
ONEM
37
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $55.1M | 0.82% |
1,666,963
+1,104,649
| +196% | +$36.5M |
|
|
NGM
38
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $55.1M | 0.81% |
2,792,448
+40,633
| +1% | +$801K |
|
|
TCRR
39
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $53.1M | 0.79% |
3,235,809
-374,979
| -10% | -$6.15M |
|
40
Genmab
GMAB
$16.7B
| $50.1M | 0.74% |
1,227,588
-104,624
| -8% | -$4.27M |
|
41
ALX Oncology
ALXO
$54.6M
| $50M | 0.74% |
914,035
-64,565
| -7% | -$3.53M |
|
42
SelectQuote
SLQT
$366M
| $46.5M | 0.69% |
2,411,957
+406,903
| +20% | +$7.84M |
|
43
ICU Medical
ICUI
$3.06B
| $45.9M | 0.68% |
222,929
-1,225
| -0.5% | -$252K |
|
44
Nuvation Bio
NUVB
$1.08B
| $42.3M | 0.63% |
4,541,009
| – | – |
|
45
Elevance Health
ELV
$72.4B
| $41.5M | 0.61% |
108,801
-21,604
| -17% | -$8.25M |
|
46
Charles River Laboratories
CRL
$7.99B
| $40.1M | 0.59% |
108,374
-58,305
| -35% | -$21.6M |
|
47
Cigna
CI
$80.2B
| $37.9M | 0.56% |
159,727
-120,330
| -43% | -$28.5M |
|
48
UnitedHealth
UNH
$279B
| $37.8M | 0.56% |
94,465
-19,911
| -17% | -$7.97M |
|
49
Neurogene
NGNE
$284M
| $36.2M | 0.54% |
3,919,235
-198,334
| -5% | -$1.83M |
|
|
50
Lifestance Health
LFST
$2.14B
| $35M | 0.52% |
+1,257,067
| New | +$35M |
|